Rheumatic diseases in migrant patients resident in Tuscany: epidemiological data analysis and single-center experience

被引:0
|
作者
Cometi, L. [1 ]
Francesconi, P. [2 ]
Bellini, B. [2 ]
Turco, L. [2 ]
Voller, F. [2 ]
Nacci, F. [1 ]
Bellando-Randone, S. [1 ]
Matucci-Cerinic, M. [1 ,3 ]
Guiducci, S. [1 ]
机构
[1] Univ Florence, Div Rheumatol, Dept Expt & Clin Med, AOU Careggi, Florence, Italy
[2] Reg Hlth Author, Florence, Italy
[3] IRCCS San Raffaele Hosp, Unit Immunol Rheumatol Allergy & Rare Dis, Milan, Italy
关键词
Migrant patients; rheumatologic diseases; epidemiology; Tuscany;
D O I
10.4081/reumatismo.2024.1547
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. In the last decades, the number of foreigners in Tuscany has considerably increased with a multiethnic distribution. We reviewed the main rheumatic diseases in the foreign population resident in Tuscany and also reported the experience at the Rheumatology Division of the University Hospital of Careggi, Florence, in order to identify the areas of origin of these patients and the main rheumatic diseases observed in them. Methods. The collaboration with the Tuscan Region provided data about foreign patients residing in Tuscany on January 1, 2021 (country of origin, chronic diseases). Moreover, we conducted a retrospective review of the clinical charts of our Rheumatologic Division from January 1, 2019, to December 31, 2020. Results. In Tuscany, on January 1, 2021, there were 61,373 patients with chronic inflammatory rheumatic diseases, and 3994 of them (6.51%) were foreigners. Most patients were born in Europe (39.03%), followed by the Balkans (15%), South America (11.27%), and North Africa (10.31%). Inflammatory joint diseases, Sjogren syndrome, and systemic lupus erythematosus were the most frequent diseases. In the period 2019-2020, 511 foreign patients visited our Rheumatology Division and mainly originated from the Balkans (34.64%), South America (18%), and European countries (16.44%). In these patients, chronic inflammatory joint diseases and connective tissue diseases (systemic sclerosis, Sjogren syndrome, and systemic lupus erythematosus) were the most prevalent diseases. Conclusions. This study provides a picture of the rheumatic diseases affecting foreign patients residing in Tuscany that are in agreement with the epidemiological data previously provided.
引用
收藏
页码:43 / 51
页数:9
相关论文
共 50 条
  • [1] TOFACITINIB TREATMENT IN CHILDREN WITH RHEUMATIC DISEASES: SINGLE-CENTER EXPERIENCE
    Kostik, M.
    Raupov, R.
    Suspitsin, E.
    Isupova, E.
    Gabrusskaya, T.
    Dubko, M.
    Snegireva, L.
    Masalova, V.
    Ermachenkova, T.
    Sorokina, L.
    Likhacheva, T.
    Kaneva, M.
    Gaidar, E.
    Kalashnikova, O.
    Chasnyk, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 247 - 248
  • [2] EFFICACY OF ANAKINRA TREATMENT IN PEDIATRIC RHEUMATIC DISEASES; A SINGLE-CENTER EXPERIENCE
    Demir, F.
    Gurler, E.
    Colak, B.
    Sozeri, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1779 - 1780
  • [3] Therapeutic apheresis treatment in rheumatic diseases: Insights from a single-center experience
    Gunes, Ezgi Cimen
    Tekgoz, Emre
    Colak, Seda
    Sayin, Selim
    Sirin, Huelya
    Ayli, Meltem
    Cinar, Muhammet
    Yilmaz, Sedat
    THERAPEUTIC APHERESIS AND DIALYSIS, 2025, 29 (01) : 123 - 130
  • [4] Risk of malignancy and biologic therapy in rheumatic inflammatory diseases: A single-center experience
    Cometi, Laura
    Bruni, Cosimo
    Passavanti, Saverio
    Tofani, Lorenzo
    Bartoli, Francesca
    Fiori, Ginevra
    Nacci, Francesca
    Lepri, Gemma
    Orlandi, Martina
    Melchiorre, Daniela
    Antonuzzo, Lorenzo
    Matucci-Cerinic, Marco
    Moggi-Pignone, Alberto
    RHEUMATOLOGY AND IMMUNOLOGY RESEARCH, 2020, 1 (01): : 39 - 45
  • [5] Efficacy of anakinra treatment in pediatric rheumatic diseases: Our single-center experience
    Demir, Ferhat
    Gurler, Eda
    Sozeri, Betul
    ARCHIVES OF RHEUMATOLOGY, 2022, 37 (03) : 435 - 443
  • [6] The prevalence and clinical spectrum of post-Covid syndrome in patients with rheumatic diseases: a single-center experience
    Batibay, S.
    Ulucakoy, R. Kocak
    Gunendi, Z.
    Gogus, F.
    REUMATISMO, 2022, 74 (01) : 22 - 28
  • [7] MACROPHAGE ACTIVATION SYNDROME IN PATIENTS WITH RHEUMATIC DISEASES - SINGLE CENTER EXPERIENCE
    Rodionovskaya, S.
    Nikishina, I.
    Alakaeva, I.
    Kaleda, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 392 - 392
  • [8] Extremely high erythrocyte sedimentation rate revisited in rheumatic diseases: a single-center experience
    Ozsoy, Zehra
    Bilgin, Emre
    Aksun, Melek Seren
    Eroglu, Imdat
    Kalyoncu, Umut
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2022, 52 (06) : 1889 - 1899
  • [9] Off-label use of rituximab in refractory pediatric rheumatic diseases: a single-center experience
    Francisca Aguiar
    Joana Abelha-Aleixo
    Mariana Rodrigues
    Iva Brito
    Pediatric Rheumatology, 12 (Suppl 1)
  • [10] Renal transplantation for patients with autoimmune diseases - Single-center experience with 42 patients
    Haubitz, M
    Kliem, V
    Koch, KM
    Nashan, B
    Schlitt, HJ
    Pichlmayr, R
    Brunkhorst, R
    TRANSPLANTATION, 1997, 63 (09) : 1251 - 1257